analysi
human
memori
b
cell
repertoir
fundament
practic
signific
develop
simpl
method
select
activ
memori
b
cell
total
fresh
frozen
pbmc
use
combin
condit
memori
b
cell
gener
clone
produc
averag
ng
igg
day
method
use
measur
frequenc
antigen
specif
memori
b
cell
well
fine
specif
crossreact
neutral
activ
secret
antibodi
follow
influenza
vaccin
specif
b
cell
expand
dramat
reach
total
clonabl
memori
b
cell
day
specif
b
cell
expans
detect
also
individu
show
signific
serolog
respons
dynam
chang
persist
b
cell
specif
varieti
pathogen
document
serial
pbmc
sampl
collect
almost
two
decad
result
reveal
novel
aspect
memori
b
cell
kinet
provid
power
tool
monitor
immun
respons
follow
infect
vaccin
respons
antigen
stimul
specif
b
lymphocyt
undergo
clonal
expans
class
switch
somat
hypermut
lead
select
antibodi
increas
affin
clonal
expand
b
cell
differenti
plasma
cell
secret
antibodi
high
rate
persist
nich
bone
marrow
other
becom
memori
b
cell
latter
rapidli
respond
antigen
restimul
suggest
may
contribut
maintain
plasma
cell
pool
therefor
serum
antibodi
level
prolong
period
time
human
memori
b
cell
compris
igm
popul
relat
mous
margin
zone
b
cell
carri
prediversifi
ig
repertoir
well
switch
popul
b
cell
express
surfac
igg
iga
human
memori
b
cell
identifi
accord
express
varieti
marker
includ
transport
characterist
matur
b
cell
memori
b
cell
known
persist
lifetim
therefor
carri
histori
individu
immun
respons
persist
memori
b
cell
well
document
much
less
inform
home
short
medium
term
dynam
memori
b
cell
follow
infect
vaccin
therefor
consider
interest
develop
simpl
method
analys
composit
human
memori
b
cell
repertoir
approach
would
consider
extend
classic
serolog
analysi
address
function
fine
specif
crossreact
antibodi
respons
clonal
level
method
would
also
suitabl
studi
dynam
specif
memori
b
cell
may
reflect
dynam
serum
antibodi
specif
memori
b
cell
identifi
isol
flow
cytometri
use
fluoresc
antigen
method
use
measur
increas
memori
b
cell
follow
vaccin
requir
highli
purifi
label
antigen
readili
appli
studi
respons
complex
multipl
antigen
addit
provid
inform
function
properti
antibodi
instanc
viral
neutral
altern
approach
follow
sever
laboratori
activ
b
cell
polyclon
measur
specif
antibodi
secret
b
cell
cultur
supernat
use
alloreact
helper
clone
demonstr
approxim
circul
b
cell
could
clonal
expand
result
clonal
product
ng
igg
subsequ
studi
thymoma
cell
use
activ
total
b
cell
high
effici
lower
clonal
ig
product
recent
report
memori
b
cell
select
trigger
tlr
agonist
use
agonist
cpg
drive
polyclon
memori
b
cell
activ
two
recent
studi
combin
tlr
stimul
addit
stimuli
staphylococcu
aureu
cowan
sac
pokewe
mitogen
pwm
cytokin
cocktail
first
use
total
pbmc
stimul
pwm
sac
cpg
readout
elispot
assay
frequenc
specif
b
cell
estim
ratio
cell
secret
specif
igg
antibodi
versu
iggsecret
cell
second
studi
use
human
purifi
b
cell
stimul
sac
pwm
cpg
lp
presenc
feeder
limit
dilut
assay
measur
frequenc
b
cell
specif
sever
antigen
studi
describ
simpl
reliabl
method
select
activ
memori
b
cell
use
fresh
cryopreserv
pbmc
use
method
analys
memori
b
cell
repertoir
dynam
follow
infect
vaccin
establish
simpl
reliabl
method
quantit
assess
human
memori
b
cell
repertoir
clonal
level
search
cultur
condit
would
drive
select
expans
differenti
human
memori
b
cell
igm
igg
memori
b
cell
cell
isol
peripher
blood
healthi
donor
label
cfse
seed
cellswel
ubottom
micropl
presenc
autolog
irradi
pbmc
cultur
stimul
differ
combin
tlr
agonist
cpg
lp
cytokin
cell
b
cell
prolifer
measur
cfse
dilut
day
total
igg
product
measur
elisa
day
cultur
supernat
condit
test
combin
agonist
high
dose
minim
effect
select
prolifer
memori
b
cell
induct
igg
secret
fig
b
select
agonist
select
agonist
also
effect
wherea
cpg
agonist
less
effici
lp
agonist
virtual
uneffect
strongli
promot
memori
b
cell
prolifer
differenti
minor
effect
boost
b
cell
prolifer
class
switch
inhibit
memori
b
cell
prolifer
igg
product
figur
supplementari
figur
final
addit
cell
cultur
stimul
induc
prolifer
b
cell
increas
prolifer
moreov
inhibit
igg
product
memori
b
cell
fig
b
supplementari
figur
pwm
sac
provid
modest
stimul
actual
inhibit
memori
b
cell
prolifer
igg
product
induc
data
shown
experi
highli
purifi
memori
b
cell
stimul
presenc
irradi
autolog
pbmc
act
feeder
cell
order
develop
simpl
method
memori
b
cell
repertoir
analysi
ask
whether
combin
could
use
activ
expans
memori
b
cell
cultur
total
pbmc
pbmc
sampl
contain
total
b
cell
cultur
low
densiti
cellscultur
presenc
total
cell
number
increas
fold
day
cell
recov
b
cell
fig
furthermor
cell
express
reduc
level
characterist
differenti
asc
day
percentag
igm
igg
iga
asc
cultur
condit
account
total
cell
fig
high
amount
igm
igg
iga
present
day
cultur
supernat
proport
roughli
reflect
frequenc
memori
b
cell
express
correspond
surfac
ig
isotyp
pbmc
fig
note
compar
result
obtain
use
freshli
isol
cryopreserv
pbmc
data
shown
conclud
stimul
total
pbmc
provid
select
effici
simpl
method
clonal
expans
differenti
human
memori
b
cell
use
freshli
isol
cryopreserv
sampl
total
pbmc
memori
lymphocyt
known
heterogen
reduc
prolif
capac
compar
cell
therefor
import
establish
frequenc
memori
b
cell
capabl
gener
clone
asc
well
size
cultur
condit
experi
report
figur
sort
igg
memori
b
cell
seed
cellscultur
replic
presenc
lightli
irradi
gy
autolog
pbmc
feeder
cell
stimul
thirti
three
cultur
receiv
averag
input
b
cellwel
contain
day
igg
amount
rang
ngcultur
data
indic
clone
effici
averag
burst
size
ng
igg
differ
experi
use
sort
igg
memori
b
cell
clone
effici
rang
igg
burst
size
ngcultur
rang
ng
fig
c
note
cultur
contain
b
cell
produc
averag
igg
fig
amount
consist
input
b
cell
produc
ng
igg
limit
dilut
experi
use
total
pbmc
contain
known
amount
igg
memori
b
cell
stimul
clone
effici
rang
fig
e
clone
effici
calcul
total
pbmc
sort
igg
memori
b
cell
non
significantli
differ
fig
e
estim
rate
ig
synthesi
singl
asc
harvest
cell
day
wash
plate
grade
number
elispot
convent
cultur
plate
compar
number
igg
spot
form
amount
igg
releas
hour
could
estim
asc
secret
averag
pgcellday
next
assess
whether
method
use
quantit
qualit
analysi
memori
b
cell
repertoir
pbmc
immun
donor
stimul
well
ubottom
plate
order
detect
clonal
antibodi
product
differ
number
pbmc
rang
cellswel
stimul
replic
cultur
percentag
igg
b
cell
pbmc
measur
begin
experi
accordingli
surfac
express
igg
igg
antibodi
day
cultur
supernat
analyz
elisa
plate
coat
tetanu
toxoid
tt
measl
viru
antigen
mv
varicella
zoster
viru
antigen
vzv
control
uncoat
plate
cultur
produc
specif
antibodi
could
detect
three
antigen
frequenc
specif
memori
b
cell
could
estim
limit
dilut
analysi
notabl
donor
cultur
contain
sticki
igg
antibodi
may
relat
polyspecif
antibodi
detect
frequenc
rang
undetect
level
antibodi
bound
control
uncoat
plate
well
antigenco
plate
exclud
analysi
experi
shown
fig
b
frequenc
mv
specif
igg
memori
b
cell
total
pbmc
correspond
igg
memori
b
cell
frequenc
ttand
vzvspecif
b
cell
lower
pbmc
correspond
memori
b
cell
respect
cultur
contain
antibodi
specif
unrel
antigen
segreg
independ
determin
chisquarebas
correl
test
compar
figur
obtain
test
frozen
fresh
pbmc
sampl
collect
time
day
apart
data
shown
understand
relationship
bind
neutral
antibodi
analyz
pbmc
three
mvimmun
donor
measur
cultur
supernat
antibodi
bound
mv
antigen
elisa
antibodi
neutral
mv
infect
vero
cell
fig
cultur
contain
mvneutral
antibodi
case
small
fraction
contain
mvbind
antibodi
three
donor
analyz
independ
size
memori
b
cell
pool
vari
consider
among
individu
test
experi
frequenc
antigenspecif
igg
memori
b
cell
express
rel
total
number
igg
memori
b
cell
plate
figur
underestim
sinc
igg
memori
b
cell
capabl
clonal
antibodi
product
cultur
condit
inde
would
correct
express
frequenc
specif
b
cell
rel
clonabl
rather
total
b
cell
order
establish
memori
b
cell
frequenc
use
independ
method
isol
larg
number
igg
ebvimmort
b
cell
clone
describ
measur
among
frequenc
b
cell
specif
mv
influenza
ha
influenza
vaccin
viru
antigen
pbmc
sampl
use
polyclon
activ
method
determin
memori
b
cell
frequenc
clone
effici
result
tabl
indic
frequenc
rel
clonabl
b
cell
good
agreement
estim
random
ebvb
cell
clone
find
indic
import
take
account
clone
effici
estim
frequenc
specif
memori
b
cell
use
method
base
activ
clonal
expans
b
cell
subsequ
refer
calcul
frequenc
memori
b
cell
clonabl
fraction
appreci
circul
asc
rise
rapidli
transient
follow
booster
immun
concomit
rise
serum
antibodi
level
much
less
known
concern
kinet
antigenspecif
memori
b
cell
use
method
measur
one
individu
frequenc
vaccinespecif
b
cell
differ
time
immun
season
influenza
vaccin
contain
anew
antigen
fig
polyclon
activ
measur
cultur
supernat
antibodi
bind
anew
hemagglutinin
ha
neutral
anew
viru
infect
mdck
cell
specif
b
cell
produc
bind
neutral
antibodi
show
mark
increas
fold
peak
day
plasmablast
serum
antibodi
reach
peak
level
day
figur
data
shown
indic
memori
b
cell
plasmablast
differ
kinet
peripher
blood
neutral
antibodi
also
bound
ha
sever
habind
antibodi
fail
neutral
viru
frequenc
b
cell
make
bind
viru
neutral
antibodi
decreas
two
fold
follow
day
investig
relationship
memori
b
cell
respons
serolog
respons
volunt
immun
season
influenza
vaccin
measur
frequenc
total
vaccinespecif
igg
b
cell
specif
serum
igg
antibodi
level
day
vaccin
fig
individu
show
increas
vaccinespecif
b
cell
rang
fold
donor
vaccin
specif
cell
exceed
clonabl
b
cell
individu
donor
show
mani
clonabl
igg
memori
b
cell
vaccinespecif
three
except
c
f
igg
antibodi
level
increas
serum
vaccin
fold
fig
overal
correl
increas
serum
antibodi
memori
b
cell
remark
except
fig
particular
two
donor
c
show
serolog
respons
spite
sharp
increas
memori
b
cell
case
j
serolog
respons
higher
increas
specif
b
cell
result
indic
kinet
vaccineinduc
b
cell
expans
remark
differ
report
circul
asc
sinc
peak
approxim
one
week
later
decreas
slowli
follow
week
addit
expans
specif
b
cell
account
mani
clonabl
b
cell
final
magnitud
b
cell
respons
necessarili
reflect
magnitud
antibodi
respons
follow
kinet
memori
b
cell
extend
period
time
took
advantag
fact
method
describ
effect
use
cryopreserv
sampl
million
cell
multipl
assay
run
cultur
supernat
therefor
use
sampl
cryopreserv
pbmc
collect
donor
period
year
measur
frequenc
memori
b
cell
five
microbi
antigen
two
analyz
fine
specif
function
produc
antibodi
fig
tabl
vzvspecif
memori
b
cell
present
high
frequenc
clonabl
b
cell
sampl
collect
month
varicella
infect
progress
decreas
year
period
reach
sampl
toxoplasma
gondii
tg
specif
igg
memori
b
cell
absent
sampl
present
high
frequenc
clonabl
b
cell
sampl
one
year
primari
tg
infect
decreas
sampl
ttspecif
memori
b
cell
present
rel
constant
frequenc
sampl
increas
two
fold
follow
booster
immun
remark
follow
mv
infect
donor
show
constant
high
level
bind
neutral
mvspecif
memori
b
cell
rang
throughout
period
observ
sampl
analys
memori
b
cell
specif
recombin
ha
differ
influenza
viru
isol
tabl
taken
togeth
result
indic
human
b
cell
repertoir
show
dynam
behaviour
period
almost
two
decad
larg
fraction
clonabl
total
repertoir
occupi
cell
given
specif
high
frequenc
memori
b
cell
maintain
half
centuri
studi
describ
simpl
method
clonal
analysi
human
memori
b
cell
repertoir
effici
reproduc
use
total
cryopreserv
pbmc
use
method
determin
fine
specif
virusspecif
memori
b
cell
relationship
viral
bind
neutral
antibodi
kinet
antigen
specif
b
cell
follow
infect
vaccin
method
develop
simpl
sinc
use
total
unfraction
pbmc
two
stimuli
agonist
high
dose
stimuli
identifi
effici
select
memori
b
cell
activ
among
condit
test
includ
sever
tlr
agonist
cytokin
total
pbmc
stimul
directli
memori
b
cell
constitut
express
well
myeloid
cell
express
produc
cytokin
support
b
cell
prolifer
differenti
inde
compar
result
obtain
use
combin
tlr
agonist
select
b
myeloid
cell
instanc
cpg
lp
known
growth
factor
nk
cell
also
activ
b
cell
remark
spite
high
dose
use
observ
outgrowth
nk
cell
day
cultur
period
addit
polyclon
stimuli
cpg
use
author
found
increas
memori
b
cell
activ
current
result
consist
previou
report
indic
distinct
requir
activ
memori
b
cell
use
limit
dilut
experi
establish
cultur
stimul
memori
b
cell
select
activ
clone
effici
rang
activ
b
cell
clone
produc
averag
ng
igg
individu
asc
secret
pg
iggcellday
although
present
studi
focus
igg
memori
b
cell
isotyp
includ
igg
subclass
igm
iga
produc
proport
reflect
frequenc
b
cell
memori
repertoir
method
therefor
suitabl
investig
iga
respons
follow
mucos
infect
vaccin
well
respons
igmproduc
human
mzlike
b
cell
find
fraction
memori
b
cell
show
vitro
expans
potenti
preced
cell
field
inde
shown
clone
capac
expans
potenti
maxim
cell
progress
reduc
central
memori
cell
effector
memori
cell
result
consist
notion
expans
potenti
b
cell
reduc
cell
enter
memori
pool
also
support
observ
use
improv
ebv
immort
method
b
cell
immort
high
effici
close
memori
b
cell
show
effici
rang
dc
unpublish
polyclon
activ
method
use
monitor
antigenspecif
b
cell
immun
donor
respons
influenza
vaccin
use
method
possibl
measur
simultan
frequenc
memori
b
cell
rel
clonabl
b
cell
defin
fine
specif
crossreact
neutral
capac
antibodi
produc
exclud
artefact
due
presenc
polyspecif
antibodi
sever
observ
made
first
mvand
influenzaimmun
donor
analyz
memori
b
cell
produc
virusneutr
antibodi
small
fraction
produc
antibodi
bind
viral
antigen
detect
elisa
differ
particularli
strike
consid
neutral
assay
detect
definit
entir
spectrum
neutral
specif
elisa
assay
may
underestim
frequenc
b
cell
make
bind
antibodi
due
limit
represent
viral
antigen
nativ
denatur
conform
possibl
neutral
antibodi
may
undetect
insuffici
antibodi
concentr
fact
similar
proport
neutral
memori
b
cell
obtain
parallel
experi
use
polyclon
stimul
pbmc
isol
ebvimmort
b
cell
clone
dc
data
shown
suggest
polyclon
stimul
method
suitabl
detect
vitro
neutral
antibodi
perhap
surpris
fraction
antigenspecif
memori
b
cell
make
neutral
antibodi
one
consid
neutral
epitop
fraction
viral
epitop
role
memori
b
cell
produc
nonneutr
antibodi
remain
establish
possibl
antibodi
may
restrict
viral
replic
indirect
mechan
also
possibl
may
play
role
even
detriment
role
enhanc
immun
patholog
second
observ
made
relat
vaccin
respons
season
influenza
vaccin
specif
b
cell
peak
day
ie
time
point
specif
asc
virtual
decreas
background
level
remain
elev
sever
week
remark
donor
antigenspecif
b
cell
account
clonabl
b
cell
reach
increas
specif
b
cell
detect
also
individu
develop
increas
serum
antibodi
level
indic
substanti
dissoci
magnitud
plasma
cell
memori
b
cell
respons
use
pbmc
sampl
donor
collect
last
year
abl
follow
dynam
antigenspecif
memori
b
cell
surpris
find
sever
month
infect
vzv
tg
larg
proport
clonabl
memori
b
cell
still
specif
vzv
tg
antigen
frequenc
decreas
progress
period
sever
year
intriguingli
donor
maintain
high
frequenc
mvspecif
memori
b
cell
sampl
analyz
spite
infect
viru
individu
memori
b
cell
specif
influenza
virus
present
much
lower
frequenc
case
clonal
analysi
provid
relev
inform
select
b
cell
follow
exposur
differ
virus
broader
context
method
describ
provid
easi
tool
monitor
singl
cell
level
b
cell
respons
respons
vaccin
infect
address
fundament
question
fine
specif
crossreact
b
cell
respons
medium
use
throughout
invitrogen
supplement
glutamin
nonessenti
aminoacid
fetal
bovin
serum
fb
hyclon
fresh
cryopreserv
pbmc
obtain
healthi
volunt
donor
gave
written
inform
consent
research
use
blood
sampl
follow
approv
canton
ethic
committe
canton
ticino
b
lymphocyt
isol
use
microbead
miltenyi
purifi
sort
use
facsaria
bd
bioscienc
isol
igg
memori
b
cell
cell
stain
antibodi
pharmingen
immunotech
igd
bd
bioscienc
igm
iga
jackson
immunoresearch
isol
highli
purifi
b
cell
cell
label
nm
mitotrak
green
fm
molecular
probe
min
wash
stain
igg
iga
igd
antibodi
igd
cell
neg
marker
use
b
cell
experi
purifi
b
cell
label
cfse
molecular
probe
replic
cultur
total
pbmc
set
differ
cell
densiti
cellscultur
ubottom
plate
costar
experi
low
number
pbmc
sort
b
cell
analyz
lightli
irradi
gy
autolog
pbmc
cellscultur
use
feeder
cell
dose
irradi
found
suffici
complet
abolish
b
cell
activ
differenti
preserv
feeder
effect
cultur
stimul
uml
human
recombin
experi
addit
stimuli
cytokin
test
differ
combin
includ
ngml
r
system
pokewe
mitogen
pwm
ml
sigma
staphylococcu
aureu
cowan
sac
sigma
tlr
agonist
microsynth
tlrgrade
lp
invivogen
transfect
cell
cell
well
filter
plate
millipor
coat
isotypespecif
goat
antihuman
igg
iga
igm
southern
biotechnolog
pb
buffer
invitrogen
block
bsapb
serial
dilut
cell
ad
plate
incub
overnight
plate
wash
incub
biotinyl
antihuman
igg
iga
igm
southern
biotechnolog
follow
streptavidinhorseradish
peroxidas
sigma
assay
develop
sigma
chromogen
substrat
measl
viru
neutral
vero
cell
atcc
cultur
dmem
fb
plate
flat
bottom
micropl
day
measl
viru
incub
cultur
supernat
hour
ad
vero
cell
three
day
later
cell
stain
crystal
violet
sigma
methanol
neutral
antibodi
detect
capac
protect
cell
monolay
influenza
viru
neutral
mdck
cell
atcc
seed
well
day
infect
emem
fb
influenza
viru
anew
supernat
mix
fbsfree
emem
supplement
tpcktreat
trypsin
worthington
biochem
viru
growth
medium
ad
cell
min
room
temperatur
infect
cell
wash
pb
min
viru
growth
medium
ad
cultur
hour
later
supernat
remov
replenish
fresh
viru
growth
medium
three
day
infect
cell
stain
crystal
violet
methanol
total
ig
produc
cultur
supernat
measur
use
igg
iga
igm
elisa
captur
antibodi
southern
biotech
igg
iga
igm
biogenesi
bd
certifi
refer
materi
institut
refer
materi
measur
use
standard
materi
igsubclass
quantif
antigen
specif
antibodi
cultur
supernat
identifi
elisa
use
half
area
plate
corn
coat
appropri
concentr
follow
antigen
tetanu
toxoid
pbmc
stain
directli
label
antibodi
pharmingen
immunoglobulin
igm
igd
iga
igm
igd
iga
b
cell
isol
use
facsaria
immort
cellswel
replic
cultur
use
ebv
presenc
cpg
irradi
allogen
pbmc
previous
describ
frequenc
b
cell
precursor
specif
given
antigen
calcul
accordingli
poisson
distribut
follow
equat
agspecif
b
cell
ln
number
neg
well
number
total
seed
well
number
precursor
per
well
singl
hit
hypothesi
test
test
data
analyz
use
graphpad
prism
softwar
packag
result
express
mean
sd
refer
web
version
pubm
central
supplementari
materi
kinet
memori
b
cell
frequenc
follow
influenza
vaccin
pbmc
collect
differ
time
vaccin
healthi
volunt
season
influenza
vaccin
store
frozen
cell
thaw
stimul
day
cultur
supernat
analyz
presenc
antibodi
bind
recombin
anew
ha
fill
squar
neutral
anew
caledonia
viru
empti
circl
shown
kinet
memori
b
cell
frequenc
calcul
accord
poisson
distribut
express
per
thousand
clonabl
igg
memori
b
cell
day
period
influenza
vaccin
boost
b
frequenc
b
cell
produc
igg
antibodi
influenza
vaccin
antigen
mixtur
b
monoval
particl
measur
volunt
grey
bar
day
vaccin
season
influenza
vaccin
black
bar
c
antibodi
level
measur
use
elisa
serum
day
vaccin
express
reciproc
valu
linear
correl
increas
frequenc
vaccinespecif
b
cell
increas
serum
antibodi
level
vaccin
dot
line
indic
confid
interv
linear
regress
kinet
memori
b
cell
frequenc
period
year
frozen
pbmc
collect
healthi
donor
year
period
stimul
figur
cultur
contain
antibodi
specif
vzv
tt
mv
toxoplasma
gondii
tg
determin
elisa
day
cultur
supernat
cultur
contain
mvneutral
antibodi
identifi
use
viral
neutral
assay
pie
chart
show
composit
memori
igg
b
cell
repertoir
individu
time
point
analys
frequenc
specif
memori
b
cell
calcul
figur
express
percentag
clonabl
igg
memori
b
cell
